COURTNEY TUTTEROW: Open Payments
NPI 1184382418 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 43 payments from 15 companies in 2025. Trend: 2023 $807 · 2024 $725 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $146 |
| PFIZER INC. | 7 | $145 |
| Novo Nordisk Inc | 5 | $97 |
| Lilly USA, LLC | 4 | $92 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Astellas Pharma US Inc | 2 | $57 |
| ABBVIE INC. | 3 | $56 |
| Seqirus USA Inc | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Exact Sciences Corporation | 2 | $32 |
Products named: ELIQUIS, FARXIGA, TRELEGY ELLIPTA, Veozah, AIRSUPRA, Ozempic, JARDIANCE, Wegovy.
Industry payments across SC — which companies pay providers there.
